文献速递免疫规划

0、3和6月龄婴儿接种前抗体演变:麻疹、肠道病毒71型与柯萨奇病毒16型的纵向分析

Pre-vaccination evolution of antibodies among infants 0, 3 and 6months of age: A longitudinal analysis of measles, enterovirus 71 and coxsackievirus 16.
PubMed 文献 · Vaccine · 2017-06-10

该纵向研究于2013—2014年采集0、3、6月龄婴儿血清,检测麻疹IgG及EV71、CoxA16中和抗体,发现三种抗体均随时间单调下降,6月龄时抗体阳性率分别为2.7%、6.8%和5.6%,作者认为需考虑调整麻疹疫苗策略、早期接种EV71疫苗及部署CoxA16疫苗。

要点

  • 婴儿0至6月龄麻疹、EV71和CoxA16抗体水平均单调下降(p<0.001)。
  • 6月龄时麻疹、EV71和CoxA16抗体阳性率分别为2.7%、6.8%和5.6%。
  • 出生时抗体滴度较高的婴儿抗体水平下降幅度更大。

核心结论

  • 需考虑进一步修改麻疹疫苗接种策略、对EV71感染进行早期疫苗接种以及部署CoxA16疫苗,以限制极低龄婴儿感染。

研究设计与样本

  • 纵向设计,于2013—2014年采集婴儿0、3和6月龄血清。
  • 麻疹IgG抗体检测样本数分别为0月龄717份、3月龄233份、6月龄75份;EV71和CoxA16中和抗体检测样本数分别为225、217和72份。
  • 收集人口学和健康信息,采用线性混合模型(LMM)描述抗体水平随时间的变化。

主要发现

  • 接种前麻疹抗体单调下降:0、3、6月龄分别为1410、195和22 mIU/ml(p<0.001)。
  • 接种前EV71中和抗体单调下降:0、3、6月龄分别为1:19.9、1:6.3和1:4.5(p<0.001)。
  • 接种前CoxA16中和抗体单调下降:0、3、6月龄分别为1:16.3、1:5.9和1:4.5(p<0.001)。
  • 6月龄时麻疹、EV71和CoxA16抗体阳性率分别为2.7%(95%CI 0.6-8.3)、6.8%(95%CI 2.7-14.4)和5.6%(95%CI 1.9-12.7)。
  • LMM提示出生时抗体滴度较高的婴儿抗体水平下降幅度更大;EV71和CoxA16感染率均为1.3%(95%CI 0.1-6.1)。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Due to waning levels of maternal antibodies (measles; enterovirus 71, EV71; and coxsackievirus A16, CoxA16), some infants may lose protection against infection prior to vaccination. Using a longitudinal design, we examine how maternal antibody levels evolve over time in infants prior to vaccination. METHODS: In 2013-2014, we collected sera at ages 0, 3 and 6months from infants. We assayed for levels of measles IgG antibody (717, 233 and 75 sample sera tested at months 0, 3 and 6, respectively), and neutralizing antibodies for EV71 and CoxA16 (225, 217, and 72). Demographic and health information were collected, and a linear mixed model (LMM) was used to describe antibody levels over time. RESULTS: Pre-vaccination monotonic antibody decreases were observed for measles (1410, 195 and 22mIU/ml, p<0.001), EV71 (1:19.9, 6.3 and 4.5, p<0.001) and CoxA16 (1:16.3, 5.9, and 4.5, p<0.001). At 6months of age, only 2.7% (95%CI, 0.6-8.3), 6.8% (95%CI, 2.7-14.4) and 5.6% (95%CI, 1.9-12.7) of infants were antibody positive for measles, EV71 and CoxA16, respectively. LMM findings indicated that infants with higher antibody titers at birth experienced a greater loss of antibody level. An infection rate of 1.3% (95%CI, 0.1-6.1) was reported for both EV71 and CoxA16. CONCLUSIONS: Further modifications of vaccination strategies for measles, earlier vaccination for EV71 infection, and deployment of a CoxA16 vaccine need to be considered to limit infection among the very young.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Fu C, Shen J, Lu L, et al. Pre-vaccination evolution of antibodies among infants 0, 3 and 6months of age: A longitudinal analysis of measles, enterovirus 71 and coxsackievirus 16. Vaccine. 2017. PMID: 28610823. doi:10.1016/j.vaccine.2017.06.002

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。